Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Could M&A Boost Pfizer More? Jefferies Thinks So
Benzinga's M&A Chatter for Thursday May 21, 2015
What Is 'Smart Money' Shorting In This Psychotically Bullish Market (Seeking Alpha)
Related LNKD
LinkedIn Presented At The JP Morgan Conference; Here's What Happened
What A Difference A Second Makes: Are Markets Prepared For Leap Second?
LinkedIn: When A Stock Is Priced For Perfection (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Apr 2015Deutsche BankMaintainsBuy
Apr 2015JP MorganMaintainsOverweight
Mar 2015JefferiesMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

Around the Web, We're Loving...

Get Benzinga's Newsletters